As the NAFLD condition progresses, these cells release their lipid droplets, differentiate into myofibroblast-like cells and become activated, expressing α-smooth muscle actin (α-SMA) and secreting large quantities of extracellular matrix proteins which results in fibrosis. The gene discussed is ACTA1; the disease is metabolic dysfunction-associated steatotic liver disease.